| Literature DB >> 22126405 |
Mourad Chioua1, David Sucunza, Elena Soriano, Dimitra Hadjipavlou-Litina, Alberto Alcázar, Irene Ayuso, María Jesús Oset-Gasque, María Pilar González, Leticia Monjas, María Isabel Rodríguez-Franco, José Marco-Contelles, Abdelouahid Samadi.
Abstract
We report the synthesis, theoretical calculations, the antioxidant, anti-inflammatory, and neuroprotective properties, and the ability to cross the blood-brain barrier (BBB) of (Z)-α-aryl and heteroaryl-N-alkyl nitrones as potential agents for stroke treatment. The majority of nitrones compete with DMSO for hydroxyl radicals, and most of them are potent lipoxygenase inhibitors. Cell viability-related (MTT assay) studies clearly showed that nitrones 1-3 and 10 give rise to significant neuroprotection. When compounds 1-11 were tested for necrotic cell death (LDH release test) nitrones 1-3, 6, 7, and 9 proved to be neuroprotective agents. In vitro evaluation of the BBB penetration of selected nitrones 1, 2, 10, and 11 using the PAMPA-BBB assay showed that all of them cross the BBB. Permeable quinoline nitrones 2 and 3 show potent combined antioxidant and neuroprotective properties and, therefore, can be considered as new lead compounds for further development in specific tests for potential stroke treatment.Entities:
Mesh:
Substances:
Year: 2011 PMID: 22126405 DOI: 10.1021/jm201105a
Source DB: PubMed Journal: J Med Chem ISSN: 0022-2623 Impact factor: 7.446